AIP
VYGR icon

Ameritas Investment Partners’s Voyager Therapeutics VYGR Stock Holding History

Ameritas Investment Partners’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.7K Hold
3,923
– – ﹤0.01% 2928
2026
Q1 		$15.1K Hold
3,923
– – ﹤0.01% 2722
2025
Q4 		$15.4K Hold
3,923
– – ﹤0.01% 2760
2025
Q3 		$18.3K Hold
3,923
– – ﹤0.01% 2701
2025
Q2 		$12.2K Hold
3,923
– – ﹤0.01% 2904
2025
Q1 		$13.3K Hold
3,923
– – ﹤0.01% 2716
2024
Q4 		$22.2K Hold
3,923
– – ﹤0.01% 2589
2024
Q3 		$22.9K Hold
3,923
– – ﹤0.01% 2577
2024
Q2 		$31K Hold
3,923
– – ﹤0.01% 2401
2024
Q1 		$36.5K Buy
3,923
+1,300
+50% +$11K ﹤0.01% 2302
2023
Q4 		$22.1K Hold
2,623
– – ﹤0.01% 2543
2023
Q3 		$20.3K Hold
2,623
– – ﹤0.01% 2531
2023
Q2 		$30K Buy
+2,623
New +$27.1K ﹤0.01% 2332
2021
Q2 		– Sell
-2,021
Closed -$10K – 3237
2021
Q1 		$10K Hold
2,021
– – ﹤0.01% 2872
2020
Q4 		$14K Hold
2,021
– – ﹤0.01% 2658
2020
Q3 		$22K Hold
2,021
– – ﹤0.01% 2333
2020
Q2 		$26K Hold
2,021
– – ﹤0.01% 2221
2020
Q1 		$18K Hold
2,021
– – ﹤0.01% 2245
2019
Q4 		$28K Hold
2,021
– – ﹤0.01% 2244
2019
Q3 		$35K Buy
2,021
+300
+17% +$6.3K ﹤0.01% 2092
2019
Q2 		$47K Hold
1,721
– – ﹤0.01% 1951
2019
Q1 		$33K Hold
1,721
– – ﹤0.01% 2104
2018
Q4 		$16K Hold
1,721
– – ﹤0.01% 2469
2018
Q3 		$33K Hold
1,721
– – ﹤0.01% 2229
2018
Q2 		$34K Buy
1,721
+481
+39% +$9.51K ﹤0.01% 2222
2018
Q1 		$23K Hold
1,240
– – ﹤0.01% 2358
2017
Q4 		$21K Buy
1,240
+719
+138% +$12.3K ﹤0.01% 2411
2017
Q3 		$5K Hold
521
– – ﹤0.01% 2923
2017
Q2 		$5K Hold
521
– – ﹤0.01% 2941
2017
Q1 		$7K Buy
+521
New +$6.32K ﹤0.01% 2788

Other funds holding VYGR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Ameritas Investment Partners's VYGR Position: Q2 2026 in Review

Ameritas Investment Partners held its Voyager Therapeutics (VYGR) position steady in Q2 2026 at 3,923 shares worth $13.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2928.

Ameritas Investment Partners first reported a position in VYGR in Q1 2017 and has held it in 30 quarters since. The position peaked at $47K in Q2 2019. 136 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

  • Ameritas Investment Partners held 3,923 shares of Voyager Therapeutics worth $13.7K as of Q2 2026.
  • Ameritas Investment Partners left its Voyager Therapeutics share count unchanged in Q2 2026.
  • Voyager Therapeutics made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #2928 holding.
  • Ameritas Investment Partners first reported a position in Voyager Therapeutics in Q1 2017 and has held it in 30 quarters since.
  • Ameritas Investment Partners's Voyager Therapeutics position peaked at $47K in Q2 2019.
  • 136 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.